文献速递中毒与环境急症重症综合管理与镇静镇痛

大剂量静脉脂肪乳用于疑似局麻药中毒相关的不良事件

Adverse events associated with a large dose of intravenous lipid emulsion for suspected local anesthetic toxicity.
PubMed 文献 · Clin Toxicol (Phila) · 2017-02-26
一句话结论11岁女孩疑似甲哌卡因中毒后接受66 mL/kg的20%静脉脂肪乳,出现高甘油三酯血症、代谢性酸中毒及脑MRI硬脑膜静脉窦高信号;作者建议考虑超过12.5 mL/kg/天剂量时须非常谨慎。

本文报告一例11岁、55.6 kg女孩在下颌神经阻滞注射3%甲哌卡因1.8 mL后出现面色苍白、眼球上翻和节律性肌肉抽动,因担心持续癫痫发作而给予静脉脂肪乳(ILE)三次1 mL/kg推注后以0.25 mL/kg/min输注,7小时内总剂量达3670 mL(66 mL/kg)。停ILE后2小时血清甘油三酯经多次稀释后估计为16,583 mg/dL(429 mmol/L),血液明显脂血,并出现嗜睡、呼吸急促、心动过速、代谢性酸中毒(碳酸氢根5 mmol/L)伴高乳酸血症(乳酸7.0 mmol/L)、血清实验室判读困难及非增强脑MRI硬脑膜静脉窦高信号。脂血3天内清除,患者无特殊恢复。作者指出该病例显示大剂量ILE作为解毒剂时的独特神经和代谢毒性,并建议考虑超过美国FDA营养补充最大日剂量12.5 mL/kg/天时须非常谨慎,强调跨机构、跨病房转运时监测总剂量。

要点

  • 11岁55.6 kg女孩疑似甲哌卡因中毒后接受20% ILE总剂量3670 mL(66 mL/kg)超过7小时,停输后2小时甘油三酯估计16,583 mg/dL(429 mmol/L),血液明显脂血。
  • 大剂量ILE后出现嗜睡、呼吸急促、心动过速、碳酸氢根5 mmol/L的代谢性酸中毒伴乳酸7.0 mmol/L,以及血清实验室判读困难。
  • 非增强脑MRI显示硬脑膜静脉窦高信号,脂血3天内清除,患者无特殊恢复。
  • 作者建议考虑ILE剂量超过美国FDA营养补充最大日剂量12.5 mL/kg/天时须非常谨慎。
  • 作者强调跨机构、跨病房转运时仔细监测已给予的总剂量,以避免解毒剂无意过量。

适用人群与场景

  • 11岁女孩,体重55.6 kg,在接受下颌神经阻滞注射1.8 mL安瓿3%甲哌卡因后出现面色苍白、眼球上翻和节律性肌肉抽动,因担心持续癫痫发作而接受静脉脂肪乳治疗。

处置流程与药物剂量

  • 给予20%静脉脂肪乳三次1 mL/kg推注,随后以0.25 mL/kg/min输注,7小时内总剂量3670 mL(66 mL/kg)。

红旗征与不能漏的情况

  • 嗜睡、呼吸急促、心动过速。
  • 代谢性酸中毒(血清碳酸氢根5 mmol/L)伴高乳酸血症(乳酸7.0 mmol/L)。
  • 血清实验室判读困难。
  • 非增强脑MRI显示硬脑膜静脉窦高信号。

研究设计与关键结果

  • 病例报告:11岁55.6 kg女孩接受20%静脉脂肪乳总剂量3670 mL(66 mL/kg)超过7小时,停输后2小时血清甘油三酯经多次稀释后估计为16,583 mg/dL(429 mmol/L),血液明显脂血。
  • 出现嗜睡、呼吸急促、心动过速、代谢性酸中毒(碳酸氢根5 mmol/L)伴高乳酸血症(乳酸7.0 mmol/L)、血清实验室判读困难及非增强脑MRI硬脑膜静脉窦高信号。
  • 脂血3天内清除,患者无特殊恢复。

证据类型、等级与局限

  • 病例报告。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为该病例显示大剂量ILE作为解毒剂时的独特神经和代谢毒性,并强调谨慎应用脂肪乳输注解毒。
  • 作者建议在考虑剂量超过美国FDA营养补充最大日剂量12.5 mL/kg/天时须非常谨慎。
  • 作者强调跨机构、跨病房转运时仔细监测已给予的总剂量,以避免解毒剂无意过量。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Intravenous lipid emulsion (ILE) has gained favor as a rescue treatment for cardiovascular collapse due to intravenous local anesthetic overdose, however, goals of ILE therapy are still being defined. We describe a case of a girl given 66 mL/kg of 20% lipid emulsion (ILE) in the treatment of presumed mepivacaine toxicity.

CASE REPORT: An 11-year-old girl weighing 55.6 kg developed pallor, rolling back of the eyes, and rhythmic muscle twitching after receiving a mandibular nerve block injection with a 1.8 mL ampule of 3% mepivacaine. With concern for persistent seizures she was given three 1 mL/kg boluses of ILE, followed by an infusion of 0.25 mL/kg/min. The total dose ultimately administered was 3670 mL (66 mL/kg) over 7 h. A serum triglyceride concentration, drawn 2 h after cessation of ILE infusion, was estimated to be 16,583 mg/dL (429 mmol/L) after several dilutions; her blood was grossly lipemic. Notable signs included hypersomnolence, tachypnea, and tachycardia. Other complications included apparent metabolic acidosis (serum bicarbonate of 5 mmol/L) with hyperlactatemia (lactate 7.0 mmol/L), difficulty with serum laboratory interpretation, and a non-contrast brain magnetic resonance imaging showing high signal in the dural venous sinuses. The lipemia cleared over three days and the patient recovered uneventfully. Case discussion: This case demonstrates a unique neurologic and metabolic toxicity associated with ILE given as an antidote in a high total dose, and highlights the need for cautious antidotal application of lipid emulsion infusions. Until more data is available, clinicians are advised to take great care if considering a dose in excess of 12.5 mL/kg/day, the maximum daily dosage recommended by the U.S. Food and Drug Administration for nutritional supplementation. Careful monitoring of total doses administered across institutions and hospital wards during transfers is paramount to avoid inadvertent overdose of antidotes.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Corwin DJ, Topjian A, Banwell BL, et al. Adverse events associated with a large dose of intravenous lipid emulsion for suspected local anesthetic toxicity. Clin Toxicol (Phila). 2017. PMID: 28489457. doi:10.1080/15563650.2017.1294693

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。